Skip to content

SCHEDULE 13GAccepted Feb 24, 4:16 PM ET

Aardvark Therapeutics, Inc. SCHEDULE 13G

Decheng Capital Global Life Sciences Fund IV, L.P.

Accepted (ET)

4:16 PM

Feb 24, 2025

Filed

Feb 24, 2025

Documents

2

Size

19.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.